CORONAVIRUS OUTBREAK JUST BOOSTED DEMAND FOR VYSTAR’S RUBBER GLOVES MATERIAL
The demand for hygiene items such as rubber gloves has spiked all over the world in the wake of the corona virus outbreak. The virus is highly contagious and is spreading rapidly. It has infected more than 80,000 people and killed nearly 3,000 people, mostly in China. That has resulted in the big rush for rubber gloves as hospitals take measures to ensure that they have enough supplies of safety gloves for their doctors to handle corona virus patients.
Vystar supplies high-quality natural rubber material called Vytex that is used in the making of gloves for hospitals use. Therefore, the company stands to benefit from the spike in demand for rubber gloves caused by the corona virus outbreak. Additionally, Vystar could benefit from better prices for its Vytex product. Fears about looming shortage of rubber is forcing makers of rubber gloves to make big orders for the raw material to ensure they have enough to run their operations.
ABOUT VYSTAR CORP (OTCMKTS:VYST)
Vystar is an American company with a diversified operation portfolio. The company is into natural rubber latex business and has created a patented product called Vytex. Vytex is an eco-friendly raw material used in a range of domestic, office and hospital products. In the hospital space, Vytex is used in medical devices as well as surgical and exam gloves. Vystar also makes air purification products under the RxAir brand for homes, offices and hospitals. Additionally, Vystar is into clean energy and furniture businesses.
The coronavirus outbreak in China that is now spreading around the world has created a perfect business opportunity for Vystar. The demand for hygiene products that Vystar makes are in high demand as the world battles the deadly coronavirus outbreak.
Being a small company, Vystar did not quickly capture investors’ attention as they pursued stocks of suppliers likely to benefit from the coronavirus outbreak. Now the word is getting out about Vystar and how it stands to reap from the efforts to curb the spread of the virus and that is attracting more investors to the stock.
The demand for hygiene items such as rubber gloves has spiked all over the world in the wake of the corona virus outbreak. The virus is highly contagious and is spreading rapidly. It has infected more than 80,000 people and killed nearly 3,000 people, mostly in China. That has resulted in the big rush for rubber gloves as hospitals take measures to ensure that they have enough supplies of safety gloves for their doctors to handle corona virus patients.
Vystar supplies high-quality natural rubber material called Vytex that is used in the making of gloves for hospitals use. Therefore, the company stands to benefit from the spike in demand for rubber gloves caused by the corona virus outbreak. Additionally, Vystar could benefit from better prices for its Vytex product. Fears about looming shortage of rubber is forcing makers of rubber gloves to make big orders for the raw material to ensure they have enough to run their operations.
ABOUT VYSTAR CORP (OTCMKTS:VYST)
Vystar is an American company with a diversified operation portfolio. The company is into natural rubber latex business and has created a patented product called Vytex. Vytex is an eco-friendly raw material used in a range of domestic, office and hospital products. In the hospital space, Vytex is used in medical devices as well as surgical and exam gloves. Vystar also makes air purification products under the RxAir brand for homes, offices and hospitals. Additionally, Vystar is into clean energy and furniture businesses.
The coronavirus outbreak in China that is now spreading around the world has created a perfect business opportunity for Vystar. The demand for hygiene products that Vystar makes are in high demand as the world battles the deadly coronavirus outbreak.
Being a small company, Vystar did not quickly capture investors’ attention as they pursued stocks of suppliers likely to benefit from the coronavirus outbreak. Now the word is getting out about Vystar and how it stands to reap from the efforts to curb the spread of the virus and that is attracting more investors to the stock.
1
